mizoribine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, M; Ise, K; Ishii, S; Kenjo, A; Kimura, T; Oshibe, I; Saito, T; Satoh, Y; Shimizu, H; Yamashita, M | 1 |
| Koja, S; Miura, S; Mori, S; Morimoto, K; Okazaki, H; Satomi, S; Taguchi, Y; Takeda, Y | 1 |
2 other study(ies) available for mizoribine and Alloxan Diabetes
| Article | Year |
|---|---|
Mizoribine as sole immunosuppressive agent in islet xenotransplantation models: a candidate immunosuppressant causing no adverse effects on islets.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Graft Survival; Immunosuppressive Agents; Injections, Intramuscular; Injections, Subcutaneous; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Wistar; Ribonucleosides; Transplantation, Heterologous | 2012 |
Prolongation of murine islet allograft survival by pretreatment of islets with 2-chloroadenosine.
Topics: 2-Chloroadenosine; Animals; Cell Survival; Diabetes Mellitus, Experimental; Drug Synergism; Graft Survival; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ribonucleosides; Time Factors; Transplantation, Homologous | 1993 |